Epstein Secrets

rporation Linklaters LLP Frontier Advisory Ply Ltd Sasol Limited London School of Economics and Political Science BT Group Plc United Kingdom Applied Materials Inc. USA Sri Lanka Jordan United Kingdom USA United Kingdom South Africa South Africa United Kingdom White Hat Ventures USA The Dow Chemical C

cutive Officer Business Editor Secretary-General Chief Executive Officer Chief Executive Officer Managing Director, Legal and Risk Professor of Management Practice President, Merck Vaccines Director, Center for Public Leadership Artistic and General Director Managing Partner, Strategy and Business Developme

Linklaters LLP United Kingdom Geoff Davis Chief Executive Officer White Hat Ventures USA George S. Davis Executive Vice-President and Chief Applied Materials Inc. USA Financial Officer Robed Matthews Davis Vice-President, Public Affairs The Dow Chemical USA Company Sally Davis Chief Executive Officer,

Executive Officer Amdocs Management Ltd USA Pierre Gentin Managing Director, Legal and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Publi

Linklaters LLP United Kingdom Geoff Davis Chief Executive Officer White Hat Ventures USA George S. Davis Executive Vice-President and Chief Applied Materials Inc. USA Financial Officer Robed Matthews Davis Vice-President, Public Affairs The Dow Chemical USA Company Sally Davis Chief Executive Officer,

Executive Officer Amdocs Management Ltd USA Pierre Gentin Managing Director, Legal and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Publi